The Tempo™ Personalized Diabetes Management Platform

What if you could help streamline your patients’ diabetes self-management while empowering them to follow your treatment plans?

The Tempo™ Personalized Diabetes Management Platform

What if you could help streamline your patients’ diabetes self-management while empowering them to follow your treatment plans?

Empower Patients in Their Diabetes Self-Management

Tempo is a personalized diabetes management platform that combines the Tempo prefilled insulin pen, diabetes management devices, and app-driven support to deliver personalized guidance for people with diabetes.

Automated blood glucose and insulin dose tracking*

Customizable dosing reminders and notifications

Tempo Insights™ is a clinician hub for viewing glucose trends and insulin dosing data

Integration of glucose data when paired with Dexcom Continuous Glucose Monitoring (CGM) Systems

  • *
    To transfer insulin dose-related data automatically, the Tempo Smart Button™ must be connected to the app and within 9 feet (3 meters) of the Bluetooth® wireless technology enabled mobile device. Insulin dosing information can also be entered manually.
  • Alerts and notifications must be enabled by the user.
  • Neither Tempo Insights nor TempoSmart™ is intended to replace the research, expertise, judgment, or treatment provided to patients by healthcare providers. Decisions regarding diagnosis or treatment will be made solely by the healthcare providers.
A healthcare provider examines a desktop screen showing patient data

Tempo Insights Provides a View of How Insulin Dosing Behavior May Impact Results

Tempo Insights is a clinician hub that allows you to see insulin dose details alongside glucose data to assist you in the management of your patients’ health condition and consideration of treatment options.

Learn more

Discover How Tempo Supports Diabetes Management

Along with objective data to assist with clinical decision-making, Tempo provides tools to help streamline self-management and inform in-office discussions.

Learn more

Prescribe Tempo

Get your patients started on Tempo with Tempo™ Welcome and Refill Kits.

Prescribe Tempo
  • Neither Tempo Insights nor TempoSmart is intended to replace the research, expertise, judgment, or treatment provided to patients by healthcare providers. Decisions regarding diagnosis or treatment will be made solely by the healthcare providers.

Lyumjev® (insulin lispro-aabc) injection 100 units/mL

Indication
Lyumjev is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.

Select Important Safety Information
Lyumjev is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro-aabc or any of the excipients in Lyumjev.

BASAGLAR® (insulin glargine) injection 100 units/mL

Indication
BASAGLAR is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Limitation of Use
BASAGLAR is not recommended for the treatment of diabetic ketoacidosis.

Select Important Safety Information
BASAGLAR is contraindicated during episodes of hypoglycemia, and in patients with hypersensitivity to insulin glargine or any of the excipients in BASAGLAR.

Humalog® (insulin lispro injection) 100 units/mL

Indication
Humalog is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.

Select Important Safety Information
Humalog is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro injection or any of the excipients in Humalog.